Mardstone Hospital
⚠️ High Risk
FEI: 3006023402 • Maristone Kent • UNITED KINGDOM
FEI Number
3006023402
Location
Maristone Kent
Country
UNITED KINGDOMAddress
Heritage Lane, , Maristone Kent, , United Kingdom
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 12/18/2006 | 64UDA01CARBIDOPA (INHIBITOR (DECARBOXYLASE)) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 12/18/2006 | 64UDA01CARBIDOPA (INHIBITOR (DECARBOXYLASE)) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 12/18/2006 | 64BCA37SPIRONOLACTONE (DIURETIC) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 12/18/2006 | 61LCK40TRAVOPROST (ANTI-COAGULANT) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 12/18/2006 | 62KCF10OMEPRAZOLE (ANTI-PERISTALTIC, ANTI-DIARRHEAL) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 12/18/2006 | 62JCA17ROPINIROLE HCL (ANTI-PARKINSONIAN) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 12/18/2006 | 61NCF69GABAPENTIN (ANTI-DEPRESSANT) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 12/18/2006 | 60LCA05ASPIRIN (ANALGESIC) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 12/18/2006 | 60LCF01ACETAMINOPHEN (ANALGESIC) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 12/18/2006 | 62OCA28ENALAPRIL MALEATE (ANTI-HYPERTENSIVE - PART II) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 12/18/2006 | 62OCA28ENALAPRIL MALEATE (ANTI-HYPERTENSIVE - PART II) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 12/18/2006 | 62OCA22CARVEDILOL (ANTI-HYPERTENSIVE - PART II) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 12/18/2006 | 61JCA08ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC) | 75UNAPPROVED | New York District Office (NYK-DO) |
Frequently Asked Questions
What is Mardstone Hospital's FDA import refusal history?
Mardstone Hospital (FEI: 3006023402) has 13 FDA import refusal record(s) in our database, spanning from 12/18/2006 to 12/18/2006.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Mardstone Hospital's FEI number is 3006023402.
What types of violations has Mardstone Hospital received?
Mardstone Hospital has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Mardstone Hospital come from?
All FDA import refusal data for Mardstone Hospital is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.